Skip to main content
David Oneill, DO, Family Medicine, Belleville, IL

David A Oneill DO


Physician

Join to View Full Profile
  • 311 W Lincoln StSte 200Belleville, IL 62220

  • Phone+1 618-213-7943

  • Fax+1 618-213-7944

Are you Dr. Oneill?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. David Oneill, DO is a board certified family physician in Belleville, Illinois. He is currently licensed to practice medicine in Illinois.

Education & Training

  • Southern Illinois University School of Medicine
    Southern Illinois University School of MedicineResidency, 1994 - 1997
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 1994
  • Texas College of Osteopathic Medicine
    Texas College of Osteopathic MedicineClass of 1994

Certifications & Licensure

  • IL State Medical License
    IL State License 1994 - 2026
  • IL State Medical License
    IL State License 1997 - 2026
  • Family Medicine
    American Board of Family Medicine Family Medicine

Press Mentions

  • FACIT Launches Assessment of Venture Philanthropy Models to Scale Canadian Commercialization of Cancer Research
    FACIT Launches Assessment of Venture Philanthropy Models to Scale Canadian Commercialization of Cancer ResearchNovember 6th, 2019
  • // FACIT’s Prospects Oncology Fund Invests in Ontario-Developed Medical Device and Novel Therapeutic Platform Technologies
    // FACIT’s Prospects Oncology Fund Invests in Ontario-Developed Medical Device and Novel Therapeutic Platform TechnologiesSeptember 27th, 2019
  • FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-Class WDR5 Leukemia Therapy
    FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-Class WDR5 Leukemia TherapyJanuary 29th, 2019